T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAVM
526
DELISTED
Cavium, Inc.
CAVM
| $116M | 0.02% |
2,995,311
+1,483,671
| +98% | +$73.4M |
|
527
RB Global
RBA
$16B
| $115M | 0.02% |
3,414,134
+21,451
| +0.6% | +$664K |
|
|
ALEX
528
DELISTED
Alexander & Baldwin
ALEX
| $115M | 0.02% |
3,180,558
+583,450
| +22% | +$21.5M |
|
|
B
529
Barrick Mining
B
$67.3B
| $114M | 0.02% |
5,350,349
-257,080
| -5% | -$4.58M |
|
530
NextEra Energy
NEE
$179B
| $114M | 0.02% |
3,496,068
+10,908
| +0.3% | +$327K |
|
531
Edgewell Personal Care
EPC
$1.31B
| $114M | 0.02% |
1,349,615
+93,608
| +7% | +$7.56M |
|
532
TIM SA
TIMB
$8.27B
| $114M | 0.02% |
10,776,341
-423,107
| -4% | -$4.34M |
|
533
Match Group
MTCH
$8.56B
| $114M | 0.02% |
7,530,533
+59,096
| +0.8% | +$777K |
|
|
DWRE
534
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $113M | 0.02% |
1,507,218
-284,142
| -16% | -$15.4M |
|
535
Lennar Class A
LEN
$21.1B
| $113M | 0.02% |
2,572,137
+1,003,425
| +64% | +$43.9M |
|
536
East-West Bancorp
EWBC
$18.6B
| $113M | 0.02% |
3,300,908
+142,928
| +5% | +$5.16M |
|
537
Iron Mountain
IRM
$37.7B
| $113M | 0.02% |
2,829,833
-11,940,396
| -81% | -$435M |
|
538
Duke Energy
DUK
$97.1B
| $112M | 0.02% |
1,307,338
-9,181
| -0.7% | -$734K |
|
|
WFM
539
DELISTED
Whole Foods Market Inc
WFM
| $112M | 0.02% |
3,482,724
-1,319,055
| -27% | -$41M |
|
540
Steris
STE
$23B
| $111M | 0.02% |
1,611,011
+3,280
| +0.2% | +$230K |
|
541
Align Technology
ALGN
$12.5B
| $109M | 0.02% |
1,358,485
-100,820
| -7% | -$7.71M |
|
542
Healthcare Services Group
HCSG
$1.45B
| $109M | 0.02% |
2,627,281
+17,785
| +0.7% | +$683K |
|
|
ABCO
543
DELISTED
Advisory Board Co
ABCO
| $109M | 0.02% |
3,069,207
-409,920
| -12% | -$13.5M |
|
544
Clean Harbors
CLH
$16.9B
| $108M | 0.02% |
2,079,150
-67,192
| -3% | -$3.36M |
|
545
Tenaris
TS
$26.6B
| $108M | 0.02% |
3,750,599
+1,209,835
| +48% | +$32.2M |
|
|
XLRN
546
DELISTED
Acceleron Pharma
XLRN
| $107M | 0.02% |
3,144,199
+197,060
| +7% | +$6.41M |
|
547
AZZ Inc
AZZ
$4.52B
| $107M | 0.02% |
1,778,099
+37,110
| +2% | +$2.12M |
|
|
BLUE
548
DELISTED
bluebird bio
BLUE
| $106M | 0.02% |
188,706
+21,903
| +13% | +$12.4M |
|
549
Selective Insurance
SIGI
$5.59B
| $106M | 0.02% |
2,762,900
-6,840
| -0.2% | -$247K |
|
550
Monro
MNRO
$352M
| $106M | 0.02% |
1,660,378
-62,355
| -4% | -$4.12M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.